The Discounted Cash Flow (DCF) valuation of AnaptysBio Inc (ANAB) is (414.64) USD. With the latest stock price at 26.86 USD, the upside of AnaptysBio Inc based on DCF is -1643.7%.
Based on the latest price of 26.86 USD and our DCF valuation, AnaptysBio Inc (ANAB) is a sell. selling AnaptysBio stocks now will result in a potential gain of 1643.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.1% - 8.5% | 7.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (742.65) - (291.39) | (414.64) |
| Upside | -2864.9% - -1184.8% | -1643.7% |